Study of Azacytidine Followed by GM-CSF in Patients With Myelodysplastic Syndrome (MDS)

NCT01542684 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

8

Enrollment

OTHER

Sponsor class

Stopped Slow Accrual

Conditions

Leukemia

Interventions

DRUG: Azacytidine
DRUG: GM-CSF

Sponsor

M.D. Anderson Cancer Center